- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 10, 2024 | 6.24M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 6.24M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 3.36M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $24K |
| Capex restated | Q1 2024 · Mar 31, 2023 | $17K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$2.28M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | $827K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $5.54M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $7.9M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $26.26M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $26.56M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | $7.54M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | $7.62M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $13.88M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $12.49M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $15.14M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $13.82M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $23.44M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $21.48M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $41.4M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $40.38M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.06 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.04 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.04 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $900K |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $697K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$372K |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$130K |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$397K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | $14K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $4.01M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $3.15M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $10.62M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $8.25M |
| Revenue | Q1 2024 · Mar 31, 2024 | $14.63M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $11.39M |